Global Breast Cancer Screening Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 07-Sep-2022
No. of pages: 103
Inquire Before Buying

Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.

A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Breast Cancer Screening market is projected to reach US$ 85 million by 2028 from an estimated US$ 52 million in 2022, at a CAGR of 8.4% during 2023 and 2028.

Global Breast Cancer Screening key players include Hologic, GE Healthcare, Siemen Healthineers, etc. Global top three manufacturers hold a share about 65%.

North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, both have a share about 40 percent.

In terms of product, Mammography Screening is the largest segment, with a share about 70%. And in terms of application, the largest application is Hospital, followed by Clinic.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Breast Cancer Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Breast Cancer Screening.

The Breast Cancer Screening market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Breast Cancer Screening market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Breast Cancer Screening manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Hologic

- GE Healthcare

- Siemen Healthineers

- Philips Healthcare

- Canon Medical

- Fujifilm

- Metaltronica

- Sino Medical-Device

- IMS Srl

Product Type Insights

Global markets are presented by Breast Cancer Screening type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Breast Cancer Screening are procured by the manufacturers.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Breast Cancer Screening Segment by Type

- Mammography Screening

- Breast Magnetic Resonance Imaging (MRI) Screening

- Breast Ultrasound Screening

Application Insights

This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Breast Cancer Screening market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Breast Cancer Screening market.

Breast Cancer Screening Segment by Application

- Hospital

- Clinic

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Breast Cancer Screening market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Breast Cancer Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Breast Cancer Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Breast Cancer Screening industry.

This report helps stakeholders to gain insights into which regions to target globally

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Breast Cancer Screening

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution

Global Breast Cancer Screening Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Breast Cancer Screening Product Introduction
1.2 Market by Type
1.2.1 Global Breast Cancer Screening Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Mammography Screening
1.2.3 Breast Magnetic Resonance Imaging (MRI) Screening
1.2.4 Breast Ultrasound Screening
1.3 Market by Application
1.3.1 Global Breast Cancer Screening Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Breast Cancer Screening Market Size Estimates and Forecasts
2.1.1 Global Breast Cancer Screening Revenue 2017-2028
2.1.2 Global Breast Cancer Screening Sales 2017-2028
2.2 Breast Cancer Screening Market Size by Region: 2022 Versus 2028
2.3 Breast Cancer Screening Sales by Region (2017-2028)
2.3.1 Global Breast Cancer Screening Sales by Region: 2017-2022
2.3.2 Global Breast Cancer Screening Sales Forecast by Region (2023-2028)
2.3.3 Global Breast Cancer Screening Sales Market Share by Region (2017-2028)
2.4 Breast Cancer Screening Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Breast Cancer Screening Revenue by Region: 2017-2022
2.4.2 Global Breast Cancer Screening Revenue Forecast by Region (2023-2028)
2.4.3 Global Breast Cancer Screening Revenue Market Share by Region (2017-2028)
3 Global Breast Cancer Screening by Manufacturers
3.1 Global Top Breast Cancer Screening Manufacturers by Sales
3.1.1 Global Breast Cancer Screening Sales by Manufacturer (2017-2022)
3.1.2 Global Breast Cancer Screening Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Breast Cancer Screening Manufacturers by Revenue
3.2.1 Global Breast Cancer Screening Revenue by Manufacturer (2017-2022)
3.2.2 Global Breast Cancer Screening Revenue Share by Manufacturer (2017-2022)
3.3 Global Breast Cancer Screening Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Breast Cancer Screening Manufacturers Covered: Ranking by Revenue
3.4.2 Global Breast Cancer Screening Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Breast Cancer Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Breast Cancer Screening Manufacturing Base Distribution, Product Type
3.5.1 Breast Cancer Screening Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Breast Cancer Screening Product Type
3.5.3 Date of International Manufacturers Enter into Breast Cancer Screening Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Hologic
4.1.1 Hologic Corporation Information
4.1.2 Hologic Description, Business Overview
4.1.3 Hologic Breast Cancer Screening Products Offered
4.1.4 Hologic Breast Cancer Screening Sales, Revenue and Gross Margin (2017-2022)
4.1.5 Hologic Breast Cancer Screening Sales by Product in 2021
4.1.6 Hologic Breast Cancer Screening Sales by Application in 2021
4.1.7 Hologic Breast Cancer Screening Sales by Geographic Area in 2021
4.1.8 Hologic Recent Developments
4.2 GE Healthcare
4.2.1 GE Healthcare Corporation Information
4.2.2 GE Healthcare Description, Business Overview
4.2.3 GE Healthcare Breast Cancer Screening Products Offered
4.2.4 GE Healthcare Breast Cancer Screening Sales, Revenue and Gross Margin (2017-2022)
4.2.5 GE Healthcare Breast Cancer Screening Sales by Product in 2021
4.2.6 GE Healthcare Breast Cancer Screening Sales by Application in 2021
4.2.7 GE Healthcare Breast Cancer Screening Sales by Geographic Area in 2021
4.2.8 GE Healthcare Recent Developments
4.3 Siemen Healthineers
4.3.1 Siemen Healthineers Corporation Information
4.3.2 Siemen Healthineers Description, Business Overview
4.3.3 Siemen Healthineers Breast Cancer Screening Products Offered
4.3.4 Siemen Healthineers Breast Cancer Screening Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Siemen Healthineers Breast Cancer Screening Sales by Product in 2021
4.3.6 Siemen Healthineers Breast Cancer Screening Sales by Application in 2021
4.3.7 Siemen Healthineers Breast Cancer Screening Sales by Geographic Area in 2021
4.3.8 Siemen Healthineers Recent Developments
4.4 Philips Healthcare
4.4.1 Philips Healthcare Corporation Information
4.4.2 Philips Healthcare Description, Business Overview
4.4.3 Philips Healthcare Breast Cancer Screening Products Offered
4.4.4 Philips Healthcare Breast Cancer Screening Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Philips Healthcare Breast Cancer Screening Sales by Product in 2021
4.4.6 Philips Healthcare Breast Cancer Screening Sales by Application in 2021
4.4.7 Philips Healthcare Breast Cancer Screening Sales by Geographic Area in 2021
4.4.8 Philips Healthcare Recent Developments
4.5 Canon Medical
4.5.1 Canon Medical Corporation Information
4.5.2 Canon Medical Description, Business Overview
4.5.3 Canon Medical Breast Cancer Screening Products Offered
4.5.4 Canon Medical Breast Cancer Screening Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Canon Medical Breast Cancer Screening Sales by Product in 2021
4.5.6 Canon Medical Breast Cancer Screening Sales by Application in 2021
4.5.7 Canon Medical Breast Cancer Screening Sales by Geographic Area in 2021
4.5.8 Canon Medical Recent Developments
4.6 Fujifilm
4.6.1 Fujifilm Corporation Information
4.6.2 Fujifilm Description, Business Overview
4.6.3 Fujifilm Breast Cancer Screening Products Offered
4.6.4 Fujifilm Breast Cancer Screening Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Fujifilm Breast Cancer Screening Sales by Product in 2021
4.6.6 Fujifilm Breast Cancer Screening Sales by Application in 2021
4.6.7 Fujifilm Breast Cancer Screening Sales by Geographic Area in 2021
4.6.8 Fujifilm Recent Development
4.7 Metaltronica
4.7.1 Metaltronica Corporation Information
4.7.2 Metaltronica Description, Business Overview
4.7.3 Metaltronica Breast Cancer Screening Products Offered
4.7.4 Metaltronica Breast Cancer Screening Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Metaltronica Breast Cancer Screening Sales by Product in 2021
4.7.6 Metaltronica Breast Cancer Screening Sales by Application in 2021
4.7.7 Metaltronica Breast Cancer Screening Sales by Geographic Area in 2021
4.7.8 Metaltronica Recent Development
4.8 Sino Medical-Device
4.8.1 Sino Medical-Device Corporation Information
4.8.2 Sino Medical-Device Description, Business Overview
4.8.3 Sino Medical-Device Breast Cancer Screening Products Offered
4.8.4 Sino Medical-Device Breast Cancer Screening Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Sino Medical-Device Breast Cancer Screening Sales by Product in 2021
4.8.6 Sino Medical-Device Breast Cancer Screening Sales by Application in 2021
4.8.7 Sino Medical-Device Breast Cancer Screening Sales by Geographic Area in 2021
4.8.8 Sino Medical-Device Recent Development
4.9 IMS Srl
4.9.1 IMS Srl Corporation Information
4.9.2 IMS Srl Description, Business Overview
4.9.3 IMS Srl Breast Cancer Screening Products Offered
4.9.4 IMS Srl Breast Cancer Screening Sales, Revenue and Gross Margin (2017-2022)
4.9.5 IMS Srl Breast Cancer Screening Sales by Product in 2021
4.9.6 IMS Srl Breast Cancer Screening Sales by Application in 2021
4.9.7 IMS Srl Breast Cancer Screening Sales by Geographic Area in 2021
4.9.8 IMS Srl Recent Development
5 Breakdown Data by Type
5.1 Global Breast Cancer Screening Sales by Type (2017-2028)
5.1.1 Global Breast Cancer Screening Sales by Type (2017-2022)
5.1.2 Global Breast Cancer Screening Sales Forecast by Type (2023-2028)
5.1.3 Global Breast Cancer Screening Sales Market Share by Type (2017-2028)
5.2 Global Breast Cancer Screening Revenue Forecast by Type (2017-2028)
5.2.1 Global Breast Cancer Screening Revenue by Type (2017-2022)
5.2.2 Global Breast Cancer Screening Revenue Forecast by Type (2023-2028)
5.2.3 Global Breast Cancer Screening Revenue Market Share by Type (2017-2028)
5.3 Breast Cancer Screening Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Breast Cancer Screening Sales by Application (2017-2028)
6.1.1 Global Breast Cancer Screening Sales by Application (2017-2022)
6.1.2 Global Breast Cancer Screening Sales Forecast by Application (2023-2028)
6.1.3 Global Breast Cancer Screening Sales Market Share by Application (2017-2028)
6.2 Global Breast Cancer Screening Revenue Forecast by Application (2017-2028)
6.2.1 Global Breast Cancer Screening Revenue by Application (2017-2022)
6.2.2 Global Breast Cancer Screening Revenue Forecast by Application (2023-2028)
6.2.3 Global Breast Cancer Screening Revenue Market Share by Application (2017-2028)
6.3 Breast Cancer Screening Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Breast Cancer Screening Market Size YoY Growth 2017-2028
7.2 North America Breast Cancer Screening Market Facts & Figures by Country
7.2.1 North America Breast Cancer Screening Sales by Country (2017-2028)
7.2.2 North America Breast Cancer Screening Revenue by Country (2017-2028)
7.3 North America Breast Cancer Screening Sales by Type
7.4 North America Breast Cancer Screening Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Screening Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Breast Cancer Screening Market Facts & Figures by Region
8.2.1 Asia-Pacific Breast Cancer Screening Sales by Region (2017-2028)
8.2.2 Asia-Pacific Breast Cancer Screening Revenue by Region (2017-2028)
8.3 Asia-Pacific Breast Cancer Screening Sales by Type
8.4 Asia-Pacific Breast Cancer Screening Sales by Application
9 Europe
9.1 Europe Breast Cancer Screening Market Size YoY Growth 2017-2028
9.2 Europe Breast Cancer Screening Market Facts & Figures by Country
9.2.1 Europe Breast Cancer Screening Sales by Country (2017-2028)
9.2.2 Europe Breast Cancer Screening Revenue by Country (2017-2028)
9.3 Europe Breast Cancer Screening Sales by Type
9.4 Europe Breast Cancer Screening Sales by Application
10 Latin America
10.1 Latin America Breast Cancer Screening Market Size YoY Growth 2017-2028
10.2 Latin America Breast Cancer Screening Market Facts & Figures by Country
10.2.1 Latin America Breast Cancer Screening Sales by Country (2017-2028)
10.2.2 Latin America Breast Cancer Screening Revenue by Country (2017-2028)
10.3 Latin America Breast Cancer Screening Sales by Type
10.4 Latin America Breast Cancer Screening Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Breast Cancer Screening Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Breast Cancer Screening Market Facts & Figures by Country
11.2.1 Middle East and Africa Breast Cancer Screening Sales by Country (2017-2028)
11.2.2 Middle East and Africa Breast Cancer Screening Revenue by Country (2017-2028)
11.3 Middle East and Africa Breast Cancer Screening Sales by Type
11.4 Middle East and Africa Breast Cancer Screening Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Breast Cancer Screening Supply Chain Analysis
12.2 Breast Cancer Screening Key Raw Materials and Upstream Suppliers
12.3 Breast Cancer Screening Clients Analysis
12.4 Breast Cancer Screening Sales Channel and Sales Model Analysis
12.4.1 Breast Cancer Screening Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Breast Cancer Screening Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Breast Cancer Screening Distributors
13 Market Dynamics
13.1 Breast Cancer Screening Industry Trends
13.2 Breast Cancer Screening Market Drivers
13.3 Breast Cancer Screening Market Challenges
13.4 Breast Cancer Screening Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Breast Cancer Screening Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Mammography Screening
Table 3. Major Manufacturers of Breast Magnetic Resonance Imaging (MRI) Screening
Table 4. Major Manufacturers of Breast Ultrasound Screening
Table 5. Global Breast Cancer Screening Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Breast Cancer Screening Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 7. Global Breast Cancer Screening Sales by Region (2017-2022) & (Units)
Table 8. Global Breast Cancer Screening Sales Forecast by Region (2023-2028) & (Units)
Table 9. Global Breast Cancer Screening Revenue by Region (2017-2022) & (US$ Million)
Table 10. Global Breast Cancer Screening Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 11. Global Breast Cancer Screening Sales by Manufacturer (2017-2022) & (Units)
Table 12. Global Breast Cancer Screening Sales Share by Manufacturer (2017-2022)
Table 13. Breast Cancer Screening Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 14. Breast Cancer Screening Revenue Share by Manufacturer (2017-2022)
Table 15. Key Manufacturers Breast Cancer Screening Price (2017-2022) & (K USD/Unit)
Table 16. Ranking of Global Top Breast Cancer Screening Manufacturers by Revenue (US$ Million) in 2021
Table 17. Global Breast Cancer Screening Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 18. Global Breast Cancer Screening by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Breast Cancer Screening as of 2021)
Table 19. Breast Cancer Screening Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Breast Cancer Screening Product Type
Table 21. Date of International Manufacturers Enter into Breast Cancer Screening Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Hologic Corporation Information
Table 24. Hologic Description and Business Overview
Table 25. Hologic Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 26. Hologic Breast Cancer Screening Product
Table 27. Hologic Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Product in 2021
Table 28. Hologic Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Application in 2021
Table 29. Hologic Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Geographic Area in 2021
Table 30. Hologic Recent Development
Table 31. GE Healthcare Corporation Information
Table 32. GE Healthcare Description and Business Overview
Table 33. GE Healthcare Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 34. GE Healthcare Breast Cancer Screening Product
Table 35. GE Healthcare Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Product in 2021
Table 36. GE Healthcare Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Application in 2021
Table 37. GE Healthcare Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Geographic Area in 2021
Table 38. GE Healthcare Recent Development
Table 39. Siemen Healthineers Corporation Information
Table 40. Siemen Healthineers Description and Business Overview
Table 41. Siemen Healthineers Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 42. Siemen Healthineers Breast Cancer Screening Product
Table 43. Siemen Healthineers Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Product in 2021
Table 44. Siemen Healthineers Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Application in 2021
Table 45. Siemen Healthineers Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Geographic Area in 2021
Table 46. Siemen Healthineers Recent Development
Table 47. Philips Healthcare Corporation Information
Table 48. Philips Healthcare Description and Business Overview
Table 49. Philips Healthcare Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 50. Philips Healthcare Breast Cancer Screening Product
Table 51. Philips Healthcare Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Product in 2021
Table 52. Philips Healthcare Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Application in 2021
Table 53. Philips Healthcare Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Geographic Area in 2021
Table 54. Philips Healthcare Recent Development
Table 55. Canon Medical Corporation Information
Table 56. Canon Medical Description and Business Overview
Table 57. Canon Medical Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 58. Canon Medical Breast Cancer Screening Product
Table 59. Canon Medical Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Product in 2021
Table 60. Canon Medical Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Application in 2021
Table 61. Canon Medical Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Geographic Area in 2021
Table 62. Canon Medical Recent Development
Table 63. Fujifilm Corporation Information
Table 64. Fujifilm Description and Business Overview
Table 65. Fujifilm Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 66. Fujifilm Breast Cancer Screening Product
Table 67. Fujifilm Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Product in 2021
Table 68. Fujifilm Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Application in 2021
Table 69. Fujifilm Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Geographic Area in 2021
Table 70. Metaltronica Corporation Information
Table 71. Metaltronica Description and Business Overview
Table 72. Metaltronica Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 73. Metaltronica Breast Cancer Screening Product
Table 74. Metaltronica Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Product in 2021
Table 75. Metaltronica Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Application in 2021
Table 76. Metaltronica Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Geographic Area in 2021
Table 77. Sino Medical-Device Corporation Information
Table 78. Sino Medical-Device Description and Business Overview
Table 79. Sino Medical-Device Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 80. Sino Medical-Device Breast Cancer Screening Product
Table 81. Sino Medical-Device Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Product in 2021
Table 82. Sino Medical-Device Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Application in 2021
Table 83. Sino Medical-Device Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Geographic Area in 2021
Table 84. IMS Srl Corporation Information
Table 85. IMS Srl Description and Business Overview
Table 86. IMS Srl Breast Cancer Screening Sales (Units), Revenue (US$ Million), Price (K USD/Unit) and Gross Margin (2017-2022)
Table 87. IMS Srl Breast Cancer Screening Product
Table 88. IMS Srl Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Product in 2021
Table 89. IMS Srl Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Application in 2021
Table 90. IMS Srl Breast Cancer Screening Sales Proportion of Breast Cancer Screening by Geographic Area in 2021
Table 91. Global Breast Cancer Screening Sales by Type (2017-2022) & (Units)
Table 92. Global Breast Cancer Screening Sales Forecast by Type (2023-2028) & (Units)
Table 93. Global Breast Cancer Screening Revenue by Type (2017-2022) & (US$ Million)
Table 94. Global Breast Cancer Screening Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 95. Global Breast Cancer Screening Sales by Application (2017-2022) & (Units)
Table 96. Global Breast Cancer Screening Sales Forecast by Application (2023-2028) & (Units)
Table 97. Global Breast Cancer Screening Revenue by Application (2017-2022) & (US$ Million)
Table 98. Global Breast Cancer Screening Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 99. North America Breast Cancer Screening Sales by Country (2017-2022) & (Units)
Table 100. North America Breast Cancer Screening Sales by Country (2023-2028) & (Units)
Table 101. North America Breast Cancer Screening Revenue by Country (2017-2022) & (US$ Million)
Table 102. North America Breast Cancer Screening Revenue by Country (2023-2028) & (US$ Million)
Table 103. North America Breast Cancer Screening Sales by Type (2017-2022) & (Units)
Table 104. North America Breast Cancer Screening Sales by Application (2017-2022) & (Units)
Table 105. Asia-Pacific Breast Cancer Screening Sales by Region (2017-2022) & (Units)
Table 106. Asia-Pacific Breast Cancer Screening Sales by Region (2023-2028) & (Units)
Table 107. Asia-Pacific Breast Cancer Screening Revenue by Region (2017-2028) & (US$ Million)
Table 108. Asia-Pacific Breast Cancer Screening Revenue by Region (2023-2028) & (US$ Million)
Table 109. Asia-Pacific Breast Cancer Screening Sales by Type (2017-2022) & (Units)
Table 110. Asia-Pacific Breast Cancer Screening Sales by Application (2017-2022) & (Units)
Table 111. Europe Breast Cancer Screening Sales by Country (2017-2022) & (Units)
Table 112. Europe Breast Cancer Screening Sales by Country (2023-2028) & (Units)
Table 113. Europe Breast Cancer Screening Revenue by Country (2017-2022) & (US$ Million)
Table 114. Europe Breast Cancer Screening Revenue by Country (2023-2028) & (US$ Million)
Table 115. Europe Breast Cancer Screening Sales by Type (2017-2022) & (Units)
Table 116. Europe Breast Cancer Screening Sales by Application (2017-2022) & (Units)
Table 117. Latin America Breast Cancer Screening Sales by Country (2017-2022) & (Units)
Table 118. Latin America Breast Cancer Screening Sales by Country (2023-2028) & (Units)
Table 119. Latin America Breast Cancer Screening Revenue by Country (2017-2022) & (US$ Million)
Table 120. Latin America Breast Cancer Screening Revenue by Country (2023-2028) & (US$ Million)
Table 121. Latin America Breast Cancer Screening Sales by Type (2017-2022) & (Units)
Table 122. Latin America Breast Cancer Screening Sales by Application (2017-2022) & (Units)
Table 123. Middle East and Africa Breast Cancer Screening Sales by Country (2017-2022) & (Units)
Table 124. Middle East and Africa Breast Cancer Screening Sales by Country (2023-2028) & (Units)
Table 125. Middle East and Africa Breast Cancer Screening Revenue by Country (2017-2022) & (US$ Million)
Table 126. Middle East and Africa Breast Cancer Screening Revenue by Country (2023-2028) & (US$ Million)
Table 127. Middle East and Africa Breast Cancer Screening Sales by Type (2017-2022) & (Units)
Table 128. Middle East and Africa Breast Cancer Screening Sales by Application (2017-2022) & (Units)
Table 129. Breast Cancer Screening Key Raw Materials, Industry Status and Trend
Table 130. Breast Cancer Screening Key Raw Materials and Upstream Suppliers
Table 131. Breast Cancer Screening Clients Status and Trend
Table 132. Breast Cancer Screening Typical Clients
Table 133. Breast Cancer Screening Distributors
Table 134. Breast Cancer Screening Market Trends
Table 135. Breast Cancer Screening Market Drivers
Table 136. Breast Cancer Screening Market Challenges
Table 137. Breast Cancer Screening Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Breast Cancer Screening Product Picture
Figure 2. Global Breast Cancer Screening Sales Market Share by Type in 2021 & 2028
Figure 3. Mammography Screening Product Picture
Figure 4. Breast Magnetic Resonance Imaging (MRI) Screening Product Picture
Figure 5. Breast Ultrasound Screening Product Picture
Figure 6. Global Breast Cancer Screening Sales Market Share by Application in 2021 & 2028
Figure 7. Hospital Examples
Figure 8. Clinic Examples
Figure 9. Breast Cancer Screening Report Years Considered
Figure 10. Global Breast Cancer Screening Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Breast Cancer Screening Market Size 2017-2028 (US$ Million)
Figure 12. Global Breast Cancer Screening Sales 2017-2028 (Units)
Figure 13. Global Breast Cancer Screening Market Size Market Share by Region: 2022 Versus 2028
Figure 14. Global Breast Cancer Screening Sales Market Share Forecast by Region (2017-2028)
Figure 15. Global Breast Cancer Screening Revenue Market Share by Region (2017-2028)
Figure 16. Global Breast Cancer Screening Sales Share by Manufacturer in 2021
Figure 17. Breast Cancer Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Breast Cancer Screening Sales Market Share Forecast by Type (2017-2028)
Figure 19. Global Breast Cancer Screening Revenue Market Share Forecast by Type (2017-2028)
Figure 20. Breast Cancer Screening Average Selling Price (ASP) by Type (2017-2022) & (K USD/Unit)
Figure 21. Global Breast Cancer Screening Sales Market Share Forecast by Application (2017-2028)
Figure 22. Global Breast Cancer Screening Revenue Market Share Forecast by Application (2017-2028)
Figure 23. Breast Cancer Screening Average Selling Price (ASP) by Application (2017-2022) & (K USD/Unit)
Figure 24. North America Breast Cancer Screening Revenue 2017-2028 (US$ Million)
Figure 25. North America Breast Cancer Screening Sales Market Share by Type (2017-2022)
Figure 26. North America Breast Cancer Screening Sales Market Share by Application (2017-2022)
Figure 27. Asia-Pacific Breast Cancer Screening Revenue 2017-2028 (US$ Million)
Figure 28. Asia-Pacific Breast Cancer Screening Sales Market Share by Region (2017-2028)
Figure 29. Asia-Pacific Breast Cancer Screening Revenue Market Share by Region (2017-2028)
Figure 30. Asia-Pacific Breast Cancer Screening Sales Market Share by Type (2017-2022)
Figure 31. Asia-Pacific Breast Cancer Screening Sales Market Share by Application (2017-2022)
Figure 32. Europe Breast Cancer Screening Revenue Growth Rate 2017-2028 (US$ Million)
Figure 33. Europe Breast Cancer Screening Sales Market Share by Country (2017-2028)
Figure 34. Europe Breast Cancer Screening Revenue Market Share by Country (2017-2028)
Figure 35. Europe Breast Cancer Screening Sales Market Share by Type (2017-2022)
Figure 36. Europe Breast Cancer Screening Sales Market Share by Application (2017-2022)
Figure 37. Latin America Breast Cancer Screening Revenue Growth Rate 2017-2028 (US$ Million)
Figure 38. Latin America Breast Cancer Screening Sales Market Share by Country (2017-2028)
Figure 39. Latin America Breast Cancer Screening Revenue Market Share by Country (2017-2022)
Figure 40. Latin America Breast Cancer Screening Sales Market Share by Type (2017-2022)
Figure 41. Latin America Breast Cancer Screening Sales Market Share by Application (2017-2022)
Figure 42. Middle East and Africa Breast Cancer Screening Revenue Growth Rate 2017-2028 (US$ Million)
Figure 43. Middle East and Africa Breast Cancer Screening Sales Market Share by Country (2017-2028)
Figure 44. Middle East and Africa Breast Cancer Screening Revenue Market Share by Country (2017-2028)
Figure 45. Middle East and Africa Breast Cancer Screening Sales Market Share by Type (2017-2022)
Figure 46. Middle East and Africa Breast Cancer Screening Sales Market Share by Application (2017-2022)
Figure 47. Breast Cancer Screening Supply Chain (Upstream and Downstream Market)
Figure 48. Global Production Market Share of Breast Cancer Screening Raw Materials by Region in 2021
Figure 49. Breast Cancer Screening Distribution Channels
Figure 50. Global Breast Cancer Screening Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 51. Global Breast Cancer Screening Percentage 2017-2028: Online Sales VS Offline Sales
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs